Molecular Roles of Cdk5 in Pain Signaling.
Injury and inflammation trigger activation of several critical cellular pathways in nociceptive signaling in the peripheral nervous system, but their precise molecular mechanisms have not been clearly defined. Cyclin-dependent kinase 5 (Cdk5), a serine/threonine kinase, is mainly expressed in the post-mitotic neurons, and has many important roles in the development, functions and pathophysiology of diseases of the nervous system. Although many functional roles of Cdk5 have been identified in neurons, its precise role in pain signaling has not been well determined. Experimental inflammation in the hind paws of mice resulted in increased mRNA and protein levels of Cdk5 and its activator p35, as well as the Cdk5 activity in nociceptive neurons (Pareek et al., 2006). Furthermore, we also identified that Cdk5 phosphorylates transient receptor potential vanilloid 1 (TRPV1), a key receptor that modulates agonist-induced calcium influx in the neurons (Pareek et al., 2007). We subsequently demonstrated that inflammation triggers increase in Cdk5 activity through activation of early growth response 1 (Egr-1) and p35 expression by tumor necrosis factor alpha (TNF-α) (Utreras et al., 2009). These findings suggest that Cdk5 plays an important role in pain signaling and therefore Cdk5 and its activators are potentially important drug targets for development of novel analgesics to treat neuropathic pain.
Functional Genomics Section, Laboratory of Cell and Developmental Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892.
Elias
E
Utreras
Akira
A
Futatsugi
Tej Kumar
TK
Pareek
Ashok B
AB
Kulkarni
J Neurosci. 2002 Apr 1;22(7):2590-7
11923424
J Biol Chem. 2002 Jan 4;277(1):528-34
11684694
Expert Opin Ther Targets. 2005 Aug;9(4):699-713
16083338
J Biol Chem. 2005 Apr 1;280(13):12896-901
15695523
Nat Cell Biol. 2001 May;3(5):453-9
11331872
Pain. 1997 Jun;71(2):165-78
9211478
Science. 2002 Dec 6;298(5600):1912-34
12471243
J Neurochem. 2007 Nov;103(4):1628-43
17883394
Trends Mol Med. 2002;8(4 Suppl):S32-7
11927285
Bioorg Med Chem. 2005 Jul 1;13(13):4291-9
15927836
J Neurosci. 2002 Sep 15;22(18):7879-91
12223541
J Pain. 2007 Feb;8(2):127-36
16949880
Science. 1997 Oct 10;278(5336):279-83
9323205
Neurochem Res. 2008 Oct;33(10):1970-8
18427980
EMBO J. 2005 Jan 12;24(1):209-20
15592431
Trends Mol Med. 2002 Aug;8(8):390-6
12127725
Nat Rev Drug Discov. 2007 May;6(5):357-72
17464295
Cell Cycle. 2008 Mar 15;7(6):750-3
18239462
J Neurosci. 2008 Apr 23;28(17):4533-40
18434532
Neuron. 1999 Jul;23(3):617-24
10433272
Brain Res Mol Brain Res. 1998 Nov 20;62(2):228-35
9813345
J Neurosci Res. 2006 Sep;84(4):747-54
16802322
Eur J Neurosci. 2005 Jun;21(12):3387-94
16026476
J Pharmacol Exp Ther. 2008 Apr;325(1):267-75
18178903
Biochem J. 2004 Feb 15;378(Pt 1):1-16
14653781
Mol Pain. 2007 Nov 01;3:33
17974036
Brain Res. 1994 Oct 24;661(1-2):196-206
7834371
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):791-6
16407116
Mol Biol Cell. 2007 Feb;18(2):404-13
17108320
Exp Cell Res. 2004 Apr 15;295(1):245-57
15051507
Pain. 2007 Jan;127(1-2):109-20
16996690
J Neuroimmunol. 2008 Dec 15;205(1-2):86-93
18947885
Nat Neurosci. 2007 Jul;10(7):880-886
17529984
Acta Pharmacol Sin. 2004 Aug;25(8):1027-30
15301735
J Med Chem. 2008 Sep 11;51(17):5229-42
18698753
Life Sci. 2004 Apr 9;74(21):2643-53
15041446
Handb Exp Pharmacol. 2007;(177):359-89
17087130
J Neurosci. 1999 Mar 15;19(6):2181-6
10066271
Semin Cell Dev Biol. 2006 Oct;17(5):555-64
17141538
Exp Neurol. 2007 Aug;206(2):269-79
17628541
J Neurosci. 2002 May 15;22(10):4196-204
12019337
Curr Alzheimer Res. 2007 Dec;4(5):547-9
18220519
Nat Rev Mol Cell Biol. 2001 Oct;2(10):749-59
11584302
J Biol Chem. 2003 Sep 12;278(37):35702-9
12824184
Curr Neuropharmacol. 2006 Jul;4(3):197-206
18615146
Acta Pharmacol Sin. 2005 Jan;26(1):46-50
15659113
J Pharmacol Exp Ther. 2006 Nov;319(2):832-9
16902054
Eur J Neurosci. 2008 Jul;28(1):12-9
18616564
Biol Chem. 2006 Jan;387(1):11-4
16497159
J Neurosci. 2008 Jan 9;28(2):415-24
18184784
Neurotoxicol Teratol. 2006 Sep-Oct;28(5):625-8
16962740
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12742-7
11675505
Eur J Pharmacol. 2001 Oct 19;429(1-3):23-37
11698024
J Neurochem. 1998 Dec;71(6):2600-6
9832161
J Neurosci. 2004 Sep 22;24(38):8300-9
15385613
Neuroreport. 2003 Dec 19;14(18):2403-9
14663200
Neurosci Lett. 2003 Aug 28;347(3):179-82
12875915
Neurochem Res. 2008 Oct;33(10):2008-12
18528757
Neuropsychopharmacology. 2003 May;28(5):947-55
12637947
Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):299-303
15379598
Anesth Analg. 2003 Oct;97(4):1108-1116
14500166
Neurosci Lett. 2008 Jun 6;437(3):180-3
18455869
Neuron. 2002 Oct 24;36(3):387-401
12408843
Microsc Res Tech. 1999 May 15-Jun 1;45(4-5):252-61
10383118
Cell Cycle. 2006 Mar;5(6):585-8
16552189
Br J Pharmacol. 1995 Aug;115(7):1265-75
7582555
Neuropharmacology. 2008 Mar;54(3):475-86
18082850
Cell Mol Neurobiol. 2008 May;28(3):351-69
18183483
Pharmacol Res. 2007 Jun;55(6):578-89
17548207
J Cell Sci. 2000 Mar;113 ( Pt 6):1059-68
10683153
Drug Discov Today. 2006 Jan;11(1-2):8-20
16478686
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):660-5
17194758
Br J Pharmacol. 2007 Mar;150(6):727-37
17310141
Pain. 2009 Mar;142(1-2):75-88
19167822
Biotechnol J. 2007 Aug;2(8):978-87
17526058
J Biol Chem. 2009 Jan 23;284(4):2275-84
19049962